Hofseth Biocare Asa (0Q6H)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current 0Q6H market cap is 822.16M. The company's latest EPS is NOK -0.3002 and P/E is -6.66.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Revenue | 69.25M | 87.62M | 122.33M | 218.51M | 265.54M |
| Operating Income | -92.81M | -118.53M | -128.82M | -88.17M | -110.67M |
| Net Income | -102.09M | -126.46M | -137.39M | -106.68M | -123.41M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Assets | 459.13M | 415.97M | 411.03M | 390.12M | 341.37M |
| Total Liabilities | 195.37M | 275.6M | 263M | 348.98M | 280.07M |
| Total Equity | 263.76M | 140.38M | 148.03M | 41.14M | 61.3M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Operating | -61.63M | -61.78M | -45.17M | 2.76M | -9.82M |
| Investing | -60.06M | -37.94M | -17.78M | -14.99M | -4.07M |
| Financing | 199.97M | -23.2M | 45.45M | 3.69M | 15.58M |
| Market Cap | 822.16M |
| Price to Earnings Ratio | -6.66 |
| Price to Sales Ratio | 3.1 |
| Price to Cash Ratio | 32.15 |
| Price to Book Ratio | 13.41 |
| Dividend Yield | - |
| Shares Outstanding | 411.08M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 471 |
| 52 Week Change | 0.00% |
| 52 Week High | 2.00 |
| 52 Week Low | 2.00 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Hofseth Biocare Asa |
| Address |
havnegata 11 alesund 6005 |
| Website | https://www.hofsethbiocare.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
